U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C16H18N2O6
Molecular Weight 334.3239
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of SUCCINIMIDYL-4-(N-MALEIMIDOMETHYL)CYCLOHEXANE-1-CARBOXYLATE

SMILES

O=C(ON1C(=O)CCC1=O)[C@H]2CC[C@H](CN3C(=O)C=CC3=O)CC2

InChI

InChIKey=JJAHTWIKCUJRDK-XYPYZODXSA-N
InChI=1S/C16H18N2O6/c19-12-5-6-13(20)17(12)9-10-1-3-11(4-2-10)16(23)24-18-14(21)7-8-15(18)22/h5-6,10-11H,1-4,7-9H2/t10-,11-

HIDE SMILES / InChI

Molecular Formula C16H18N2O6
Molecular Weight 334.3239
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 2 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC), an N-hydroxysuccinimide ester derived from 4-(N-maleimidomethyl)cyclohexane-1-carboxylic acid, is a non-cleavable and membrane permeable crosslinker. It is used for enzyme labelling of antibodies - both enzyme and antibody specificity can be preserved; for creation of specific bioconjugates via one- or two-step crosslinking reactions; for creation of sulfhydryl-reactive, maleimide-activated carrier proteins for coupling haptens. SMCC conjugation occurs via a maleimide group that is sulfhydryl (thiol; -SH) reactive and a NHS ester group that is amine reactive and forms stable, covalent protein crosslinks. SMCC crosslinker must be dissolved in an organic solvent, such as DMSO or DMF, and then can be added to an aqueous crosslinking reaction. SMCC crosslinking reagent is permeable across the lipid bilayer of the cell membrane and can be used to crosslink intracellular proteins and peptides.

Approval Year

PubMed

PubMed

TitleDatePubMed
Cross linking of anti-B16 melanoma monoclonal antibodies to lymphokine activated killer (LAK) cells: possible role in the therapy of B16 melanoma.
1988 Sep-Oct
Comparison of four bifunctional reagents for coupling peptides to proteins and the effect of the three moieties on the immunogenicity of the conjugates.
1989 Jun 2
Trastuzumab emtansine: first global approval.
2013 May
Preparation of Immunotoxin Herceptin-Botulinum and Killing Effects on Two Breast Cancer Cell Lines.
2015
Impacts of Cross-Linkers on Biological Effects of Mesoporous Silica Nanoparticles.
2017 Mar 22
Novel trastuzumab-DM1 conjugate: Synthesis and bio-evaluation.
2019 Aug
Substance Class Chemical
Created
by admin
on Fri Dec 15 18:33:22 UTC 2023
Edited
by admin
on Fri Dec 15 18:33:22 UTC 2023
Record UNII
B357P1G1IF
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
SUCCINIMIDYL-4-(N-MALEIMIDOMETHYL)CYCLOHEXANE-1-CARBOXYLATE
Systematic Name English
SMCC
Common Name English
CYCLOHEXANECARBOXYLIC ACID, 4-((2,5-DIHYDRO-2,5-DIOXO-1H-PYRROL-1-YL)METHYL)-, 2,5-DIOXO-1-PYRROLIDINYL ESTER
Systematic Name English
NSC-344483
Code English
1H-PYRROLE-2,5-DIONE, 1-((4-(((2,5-DIOXO-1-PYRROLIDINYL)OXY)CARBONYL)CYCLOHEXYL)METHYL)-
Systematic Name English
Code System Code Type Description
WIKIPEDIA
Succinimidyl 4-(N-maleimidomethyl)cyclohexane-1-carboxylate
Created by admin on Fri Dec 15 18:33:22 UTC 2023 , Edited by admin on Fri Dec 15 18:33:22 UTC 2023
PRIMARY
FDA UNII
B357P1G1IF
Created by admin on Fri Dec 15 18:33:22 UTC 2023 , Edited by admin on Fri Dec 15 18:33:22 UTC 2023
PRIMARY
NSC
344483
Created by admin on Fri Dec 15 18:33:22 UTC 2023 , Edited by admin on Fri Dec 15 18:33:22 UTC 2023
PRIMARY
EPA CompTox
DTXSID30215307
Created by admin on Fri Dec 15 18:33:22 UTC 2023 , Edited by admin on Fri Dec 15 18:33:22 UTC 2023
PRIMARY
CHEBI
63174
Created by admin on Fri Dec 15 18:33:22 UTC 2023 , Edited by admin on Fri Dec 15 18:33:22 UTC 2023
PRIMARY
DAILYMED
B357P1G1IF
Created by admin on Fri Dec 15 18:33:22 UTC 2023 , Edited by admin on Fri Dec 15 18:33:22 UTC 2023
PRIMARY
CAS
64987-85-5
Created by admin on Fri Dec 15 18:33:22 UTC 2023 , Edited by admin on Fri Dec 15 18:33:22 UTC 2023
PRIMARY